Images

Filter by

Figure 2 Schematic of Target Pathways of Heart Failure Devices
Figure 2: Schematic of Target Pathways of Heart Failure Devices
Figure 1 Device Therapies for Heart Failure
Figure 1: Device Therapies for Heart Failure
Figure 1 Main Processes and Pathways Modulated by Proproliferative miRNAs
Figure 1: Main Processes and Pathways Modulated by Proproliferative miRNAs
Table 1 Cont
Table 1: Cont.
Table 1 Main miRNAs That Stimulate Cardiac Repair and Regeneration and Their Relevant Target Genes and Potential Mechanism of Action in the Heart
Table 1: Main miRNAs That Stimulate Cardiac Repair and Regeneration and Their Relevant Target Genes and Potential Mechanism of Action in the Heart
Figure 1 Practical Recommendations for Cardioprotection in Oncology Patients
Figure 1: Practical Recommendations for Cardioprotection in Oncology Patients
Table 4 Ongoing Trials Investigating Sacubitril Valsartan for Prevention of Anthracycline induced Cardiotoxicity
Table 4: Ongoing Trials Investigating Sacubitril/Valsartan for Prevention of Anthracycline-induced Cardiotoxicity
Table 3 Safety Trials Evaluating Trastuzumab in Patients with Reduced Left Ventricular Ejection Fraction
Table 3: Safety Trials Evaluating Trastuzumab in Patients with Reduced Left Ventricular Ejection Fraction
Table 2 Recent Randomised Controlled Trials Evaluating Cardioprotective Strategies During Trastuzumab Treatment
Table 2: Recent Randomised Controlled Trials Evaluating Cardioprotective Strategies During Trastuzumab Treatment
Table 1 Recent Randomised Controlled Trials on Cardioprotection in Patients Receiving Anthracycline Therapy
Table 1: Recent Randomised Controlled Trials on Cardioprotection in Patients Receiving Anthracycline Therapy
Figure 5 Long term Survival of Patients with High TnI and Low TnI After Propensity Score Matching
Figure 5: Long-term Survival of Patients with High TnI and Low TnI After Propensity Score Matching
Figure 4 Median Graft Flow to Different Target Vessels
Figure 4: Median Graft Flow to Different Target Vessels